论文部分内容阅读
日前,美国FDA批准了Boehring Ingelheim公司的噻托溴铵吸入用干粉胶囊剂(tiotropium bromide/Spiriva HandiHaler)一新适应证,即用于维持治疗慢性阻塞性肺病以减少疾病恶化。噻托溴铵属长效抗胆碱能药物,是迄今
The FDA recently approved a new indication from Boehring Ingelheim for a tiotropium bromide / Spiriva HandiHaler that is used to treat chronic obstructive pulmonary disease (COPD) to reduce disease progression. Tiotropium bromide is a long-acting anticholinergic drugs, is so far